About Mylan Pharmaceuticals Private Limited
Data last updated:
Mylan Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Mylan Group Bv. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 03 March 1997 and has been in existence for over 29 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U73100TG1997PTC149781. Its GSTIN is 36AABCM9323J1ZB (Telangana). The company holds 16 GST registrations, of which 11 are active.
The company has an authorised share capital of ₹120 Cr and a paid-up capital of ₹10 Cr. It was formerly known as Merck Development Centre Private Limited and Mylan India Private Limited. It is led by directors Praveen Singh Chauhan (Whole-Time Director) and Ajay Singh Rathore (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.564/A/22 Road No.92 Jubilee Hills, Hyderabad, Telangana, India – 500096.
As per the financials filed for FY 2025, the company reported a revenue of ₹1,253.34 Cr, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹42.48 Cr (net margin 3.4%) and EBITDA of ₹172.34 Cr (EBITDA margin 13.8%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years and 11% over five years.
The company has about 3,092 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Viatris Connect India. Court records list 20 cases involving the company, including 15 filed by the company and 5 filed against it; 8 cases are pending. The company has 3 deals on record (2 secondary share transfers, 1 acquisition); the latest was in October 2021. Its 4 peer companies in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading) are compared by revenue, 2 larger and 2 smaller; the largest is Palepu Pharma Private Limited with revenue of ₹1,270.38 Cr. The company has 9 MSME Form 1 returns on record between 2019 and 2024, listing 26 overdue payments to 12 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mylan.in.
Company details
Name history
Mylan Pharmaceuticals has undergone 3 name changes throughout its history. The company was previously known as Merck Development Centre Private Limited, Mylan India Private Limited, and Mylan Development Centre Private Limited. The current legal name is Mylan Pharmaceuticals Private Limited.
| Company Name | Status |
|---|---|
| Mylan Pharmaceuticals Private Limited | Current |
| Merck Development Centre Private Limited | Previous |
| Mylan India Private Limited | Previous |
| Mylan Development Centre Private Limited | Previous |
CIN history
Mylan Pharmaceuticals has one previous CIN (Corporate Identification Number): U73100MH1997PTC106267. The current CIN is U73100TG1997PTC149781, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U73100TG1997PTC149781 | Current |
| U73100MH1997PTC106267 | Previous |
Contact details
Mylan Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its website is mylan.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No.564/A/22 Road No.92 Jubilee Hills, Hyderabad, Telangana, India – 500096
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Mylan Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Mylan Pharmaceuticals operates one associated brand: Viatris Connect India. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Online knowledge platform providing medical insights and resources for healthcare professionals in India. | viatrisconnect.in |
Business activity
The main business activity of Mylan Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Mylan Pharmaceuticals Private Limited, buy the company report.
Financials of Mylan Pharmaceuticals Private Limited
FY 2025 filings availableMylan Pharmaceuticals Private Limited reported revenue of ₹1,253.34 Cr (up 1% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 1% growth in the latest year. EBITDA rose 858% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹172.34 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹42.48 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.8% | ||||
| Net Profit Margin | 3.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mylan Pharmaceuticals Private Limited, buy the company report.
Board of directors of Mylan Pharmaceuticals Private Limited
Mylan Pharmaceuticals has 2 current directors and 22 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Praveen Singh Chauhan | Whole-Time Director | 16 Apr 2024 | 2 Years 6 Months | Current |
| Ajay Singh Rathore Also directs: Famy Life Sciences Private Limited | Whole-Time Director | 21 Jun 2019 | 7 Years 4 Months | Current |
Peer comparison
Mylan Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Palepu Pharma Private Limited | ₹1,270.38 Cr (FY 2023) | 14.0% | Hyderabad, Telangana, India | |||
| Galderma India Private Limited | ₹1,266.33 Cr (FY 2025) | 61.0% | Mumbai, Maharashtra, India | |||
| Mylan Pharmaceuticals Private Limitedthis company | ₹1,253.34 Cr (FY 2025) | ₹42.48 Cr | 3.4% | 1.0% | 3,092 | Hyderabad, Telangana, India |
| Aquatic Remedies Limited | ₹1,226.14 Cr (FY 2025) | -7.0% | Mumbai, Maharashtra, India | |||
| Sanjeevani Pharma Distributors Private Limited | ₹1,076.67 Cr (FY 2025) | 47.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Mylan Pharmaceuticals Private Limited, buy the company report.
Auditor
Mylan Pharmaceuticals Private Limited is audited by Deloitte Haskins & Sells for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Deloitte Haskins & Sells | FY 2022 | 008072S |
Shareholding
The shareholding of Mylan Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Mylan Pharmaceuticals Private Limited, buy the company report.
Deals & funding
Mylan Pharmaceuticals Private Limited has 3 deals on record (2 secondary share transfers, 1 acquisition); the latest was in October 2021.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2021 | Acquisition | ₹180.48 Cr | Buyer: Pfizer Limited Seller: Mylan Pharmaceuticals Private Limited |
| Dec 2018 | Secondary share transfer | Undisclosed | Seller: Mylan Group BV |
| Dec 2006 | Secondary share transfer | Undisclosed | Buyer: Mylan Group BV Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Mylan Pharmaceuticals Private Limited has 20 court cases on record: 15 filed by Mylan Pharmaceuticals, 5 filed against it. 8 cases are pending and 12 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 10 | 1 | 1 |
| High courts | 6 | 1 | 6 |
| Supreme Court | 3 | 2 | 1 |
| NCLT | 1 | 1 | 0 |
Cases on record (5 of 20)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, Hyderabad | Insolvency matter | Filed against the company by Dotcom Pharma Private Limited | Disposed |
| Supreme Court | Court case (1807-Ordinary Civil Matters : Others) | Filed by the company against Sovereign Pharma Private Limited Through Its Managing Director Through Its Managing Director R/O Sarosh Bhavan, 16/B-1, Dr. Ambedkar Road, Pune , District: Pune ,Pune , Maharashtra and 4 others | Disposed |
| Supreme Court | Court case (1807-Ordinary Civil Matters : Others) | Filed against the company by Roche Products India Private Limited Through Its Authorised Representative Through Its Authorised Representative A Company Incorporated Under the Companies Act, 1956, As Amended With Its Registered Office at the View 2Nd Floor, 165, Dr. Annie Besant Road Worli , District: Worli ,Mumbai , Maharashtra and 2 others | Disposed |
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Municipal Corporation of Greater Mumbai | Pending |
| High Court | Commercial suit | Filed by the company against Municipal Corporation of Greater Mumbai | Pending |
To see the full case history of Mylan Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Mylan Pharmaceuticals Private Limited has 9 MSME Form 1 returns on record between 2019 and 2024, listing 26 overdue payments to 12 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 12)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Logistics Park (India) Private Limited | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier | |||
| Monarch Pharma Lines (Hyderabad) Pvt Ltd |
To see the full MSME payment records of Mylan Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Mylan Pharmaceuticals Private Limited has a workforce of 3,092 employees on its EPFO records as of Apr 07, 2024, across 2 active EPFO establishments.
GST
Mylan Pharmaceuticals has 16 GST registrations: 11 active and 5 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AABCM9323J1ZB | Telangana | Active | 01 Jul 2017 |
| 36AABCM9323J2ZA | Telangana | Active | 07 Sep 2017 |
| 07AABCM9323J1ZC | Delhi | Active | 01 Jul 2017 |
| 09AABCM9323J1Z8 | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Mylan Pharmaceuticals Private Limited, buy the company report.
Recent activity
Mylan Pharmaceuticals Private Limited has 22 board changes on record since 2007: 2 appointments and 20 cessations. The latest: Praveen Singh Chauhan ceased to be Additional Director on 29 Sep 2024.
13 earlier events are in the company report.
News
Frequently asked questions
Mylan Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 03 March 1997 (29+ years old) and is registered under CIN U73100TG1997PTC149781.
Mylan Pharmaceuticals has 2 current directors:
- Praveen Singh Chauhan - Whole-Time Director
- Ajay Singh Rathore - Whole-Time Director
The latest financial statements of Mylan Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Mylan Pharmaceuticals is 36AABCM9323J1ZB, registered in Telangana. The company has 16 GST registrations in all, of which 11 are active and 5 are cancelled or inactive. Other active GSTINs include 36AABCM9323J2ZA (Telangana), 07AABCM9323J1ZC (Delhi), 09AABCM9323J1Z8 (Uttar Pradesh).
The CIN (Corporate Identification Number) of Mylan Pharmaceuticals is U73100TG1997PTC149781. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mylan Pharmaceuticals has 20 court cases on record: 15 filed by the company and 5 filed against it. 8 are pending. Most are in the district courts.
Mylan Pharmaceuticals was incorporated on 03 March 1997, making it 29+ years old. It is registered with the Registrar of Companies, Hyderabad.
Mylan Pharmaceuticals has 3 deals on record (2 secondary share transfers, 1 acquisition); the latest was in October 2021.
The peers of Mylan Pharmaceuticals by revenue are Palepu Pharma Private Limited, Galderma India Private Limited, Aquatic Remedies Limited, Sanjeevani Pharma Distributors Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Praveen Singh Chauhan ceased to be Additional Director on 29 Sep 2024. Praveen Singh Chauhan was appointed as Whole-Time Director on 16 Apr 2024. Rajesh Ullanat ceased to be Whole-Time Director on 03 Mar 2021. Mylan Pharmaceuticals has 22 board changes on record in total.
Mylan Pharmaceuticals has 9 MSME Form 1 returns on record between 2019 and 2024, listing 26 overdue payments to 12 micro and small suppliers. The latest return was filed on 26 Apr 2024.
Mylan Pharmaceuticals can be reached through the website mylan.in. Its registered office is in Hyderabad, Telangana, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
